Created in 2004 (United States), MedImmune, Inc. own 585 sister brands and 17478 competing brands. MedImmune, Inc. is owned by ASTRAZENECA, listed on the stock exchange of London The ISIN, the company's International Securities Identification Number, is GB0009895292. MedImmune, Inc. belongs to the Drug Manufacturers business sector.